Hayat Önyüksel

3.8k total citations · 1 hit paper
81 papers, 3.1k citations indexed

About

Hayat Önyüksel is a scholar working on Molecular Biology, Biomaterials and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hayat Önyüksel has authored 81 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 29 papers in Biomaterials and 27 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hayat Önyüksel's work include Nanoparticle-Based Drug Delivery (27 papers), Neuropeptides and Animal Physiology (27 papers) and Lipid Membrane Structure and Behavior (18 papers). Hayat Önyüksel is often cited by papers focused on Nanoparticle-Based Drug Delivery (27 papers), Neuropeptides and Animal Physiology (27 papers) and Lipid Membrane Structure and Behavior (18 papers). Hayat Önyüksel collaborates with scholars based in United States, Türkiye and Germany. Hayat Önyüksel's co-authors include Israel Rubinstein, Otilia Koo, Amrita Banerjee, Sok Bee Lim, Israel Rubinstein, Lise Arleth, Rex P. Hjelm, Ashwini Pai, V.Sagar Sethi and Eun Jung Jeon and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Langmuir.

In The Last Decade

Hayat Önyüksel

81 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of nanotechnology in targeted drug delivery and imaging: a concise review

2005 506 citations Otilia Koo, Israel Rubinstein et al. Nanomedicine Nanotechnology Biology and Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hayat Önyüksel United States	29	1.3k	1.2k	584	576	319	81	3.1k
Ho Lun Wong United States	27	1.6k 1.2×	1.7k 1.4×	809 1.4×	959 1.7×	264 0.8×	40	3.5k
Valentino Laquintana Italy	35	1.1k 0.8×	814 0.7×	604 1.0×	642 1.1×	385 1.2×	109	3.1k
Kaoxiang Sun China	34	1.4k 1.1×	1.2k 1.0×	986 1.7×	889 1.5×	251 0.8×	107	3.7k
João Nuno Moreira Portugal	34	2.1k 1.5×	974 0.8×	518 0.9×	664 1.2×	177 0.6×	104	3.5k
Barbara Ruozi Italy	35	1.7k 1.3×	1.9k 1.6×	1.1k 1.9×	1.0k 1.8×	402 1.3×	127	4.3k
Yuanying Pei China	27	1.5k 1.1×	1.5k 1.3×	714 1.2×	757 1.3×	245 0.8×	41	3.2k
Yoshiharu Minamitake Japan	15	979 0.7×	1.8k 1.5×	577 1.0×	783 1.4×	373 1.2×	29	3.5k
Francesca Re Italy	36	1.6k 1.2×	1.1k 0.9×	400 0.7×	600 1.0×	437 1.4×	123	4.2k
Karine Andrieux France	28	1.1k 0.8×	1.4k 1.2×	720 1.2×	717 1.2×	470 1.5×	68	3.2k
Hélène Chacun France	27	824 0.6×	1.0k 0.9×	543 0.9×	526 0.9×	296 0.9×	50	2.4k

Countries citing papers authored by Hayat Önyüksel

Since Specialization

Citations

This map shows the geographic impact of Hayat Önyüksel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayat Önyüksel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayat Önyüksel more than expected).

Fields of papers citing papers by Hayat Önyüksel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayat Önyüksel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayat Önyüksel. The network helps show where Hayat Önyüksel may publish in the future.

Co-authorship network of co-authors of Hayat Önyüksel

This figure shows the co-authorship network connecting the top 25 collaborators of Hayat Önyüksel. A scholar is included among the top collaborators of Hayat Önyüksel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayat Önyüksel. Hayat Önyüksel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliveira, Suellen D., et al.. (2023). Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice. Mediators of Inflammation. 2023. 1–11. 8 indexed citations

Jayawardena, Dulari, Arivarasu Natarajan Anbazhagan, Shubha Priyamvada, et al.. (2020). Colonic Delivery of Vasoactive Intestinal Peptide Nanomedicine Alleviates Colitis and Shows Promise as An Oral Capsule. Nanomedicine. 15(25). 2459–2474. 8 indexed citations

Eskandari, Zahra, et al.. (2019). NF-κB Inhibition Activity of Curcumin-Loaded Sterically Stabilized Micelles and Its Up-Regulator Effect on Enhancement of Cytotoxicity of a New Nano-Pirarubicin Formulation in the Treatment of Breast Cancer. Records of Natural Products. 13(5). 390–404. 6 indexed citations

Bahadorı, Fatemeh, Abdürrahim Koçyiğit, Hayat Önyüksel, Aydan Dağ, & Gülaçtı Topçu. (2017). Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation. Toxics. 6(1). 7–7. 16 indexed citations

Jayawardena, Dulari, Grace Guzman, Ravinder K. Gill, et al.. (2017). Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology. 313(1). G16–G25. 29 indexed citations

Jayawardena, Dulari, et al.. (2016). Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis. Nanomaterials. 6(1). 8–8. 23 indexed citations

Anbazhagan, Arivarasu Natarajan, Shubha Priyamvada, Dulari Jayawardena, et al.. (2016). GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 659–665. 59 indexed citations

Önyüksel, Hayat. (2015). Lipid based sterically stabilized micelles as effective drug carriers for cancer and inflammatory diseases. Pharmaceutica Analytica Acta. 1 indexed citations

Yuan, Zhihong, Mansoor Ali Syed, Myungsoo Joo, et al.. (2015). TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(5). L426–L438. 53 indexed citations

10.

Koo, Otilia, et al.. (2012). Nanomedicines for Inflammatory Diseases. Methods in enzymology on CD-ROM/Methods in enzymology. 508. 355–375. 16 indexed citations

11.

Lim, Sok Bee, et al.. (2011). Micellar nanomedicine of human neuropeptide Y. Nanomedicine Nanotechnology Biology and Medicine. 7(4). 464–471. 29 indexed citations

12.

Rubinstein, Israel, et al.. (2010). Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis. Pharmaceutical Research. 28(4). 776–787. 89 indexed citations

13.

Lim, Sok Bee, Israel Rubinstein, & Hayat Önyüksel. (2008). Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles. International Journal of Pharmaceutics. 356(1-2). 345–350. 45 indexed citations

14.

Önyüksel, Hayat, et al.. (2008). VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: A novel targeted nanomedicine for breast cancer. International Journal of Pharmaceutics. 365(1-2). 157–161. 49 indexed citations

15.

Koo, Otilia, Israel Rubinstein, & Hayat Önyüksel. (2005). Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine. Nanomedicine Nanotechnology Biology and Medicine. 1(1). 77–84. 80 indexed citations

16.

Rubinstein, Israel, et al.. (2003). Sterically Stabilized Phospholipid Mixed Micelles: In Vitro Evaluation as a Novel Carrier for Water-Insoluble Drugs. Pharmaceutical Research. 20(2). 297–302. 127 indexed citations

17.

Önyüksel, Hayat, et al.. (2003). Interactions of VIP, Secretin and PACAP1-38 with Phospholipids: A Biological Paradox Revisited. Current Pharmaceutical Design. 9(12). 1005–1012. 27 indexed citations

18.

Önyüksel, Hayat, et al.. (2003). Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Peptides. 24(2). 281–286. 8 indexed citations

19.

Sekosan, Marin, et al.. (2001). VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. Journal of Controlled Release. 74(1-3). 129–134. 45 indexed citations

20.

Klegerman, Melvin E., et al.. (1998). In Vitro Targeting of Acoustically Reflective Immunoliposomes to Fibrin Under Various Flow Conditions. Journal of drug targeting. 5(6). 507–518. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact